<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Watson Pharmaceuticals]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Watson Pharmaceuticals on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=174309"/>
<item>
<title><![CDATA[Actavis to Buy Warner Chilcott for $5 Billion in Stock]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/actavis-to-buy-warner-chilcott-for-5-billion-in-stock566832/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/actavis-to-buy-warner-chilcott-for-5-billion-in-stock566832/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 13:57:41 EDT]]></pubDate>
<description><![CDATA[Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specialty pharmaceutical brands--and shrinking its tax burden.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Actavis to Buy Warner Chilcott For $5 Billion in Stock]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/actavis-to-buy-warner-chilcott-for-5-billion-in-stock/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/actavis-to-buy-warner-chilcott-for-5-billion-in-stock/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 10:39:23 EDT]]></pubDate>
<description><![CDATA[Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specialty pharmaceutical brands and shrinking its tax burden.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Drugmaker Actavis in Talks to Buy Warner Chilcott]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2013/05/10/drugmaker-actavis-in-talks-to-buy-warner-chilcott/?]]></link>
<guid>http://www.foxbusiness.com/industries/2013/05/10/drugmaker-actavis-in-talks-to-buy-warner-chilcott/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 16:54:28 EDT]]></pubDate>
<description><![CDATA[The generic drugmaker said it was in early stage discussions to buy the specialty pharmaceutical company Warner Chilcott.  ]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Actavis Swings to 1st-Quarter Loss on Charges; Raises Year View]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/02/actavis-swings-to-1st-quarter-loss-on-charges-raises-year-view/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/02/actavis-swings-to-1st-quarter-loss-on-charges-raises-year-view/</guid>
<pubDate><![CDATA[Thu, 02 May 2013 09:10:59 EDT]]></pubDate>
<description><![CDATA[Actavis Inc. (ACT) swung to a first-quarter loss as acquisition, licensing and other charges masked the drug maker's revenue growth, while adjusted earnings topped consensus estimates.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Actavis Temporarily Enjoined From Selling Generic of AstraZeneca's Pulmicort Respules]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/03/actavis-temporarily-enjoined-from-selling-generic-astrazeneca-pulmicort/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/03/actavis-temporarily-enjoined-from-selling-generic-astrazeneca-pulmicort/</guid>
<pubDate><![CDATA[Wed, 03 Apr 2013 07:31:41 EDT]]></pubDate>
<description><![CDATA[Actavis Inc. (ACT) confirmed a New Jersey court has granted a motion from AstraZeneca PLC (AZN) seeking a temporary restraining order to prevent Actavis from further distributing its generic version of asthma treatment Pulmicort Respules.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Supreme Court Concerned About Drug Patent Settlements]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/03/25/supreme-court-concerned-about-drug-patent-settlements/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/03/25/supreme-court-concerned-about-drug-patent-settlements/</guid>
<pubDate><![CDATA[Mon, 25 Mar 2013 13:45:06 EDT]]></pubDate>
<description><![CDATA[Several members of the Supreme Court expressed concern Monday about patent settlements in which brand-name pharmaceutical companies pay generic-drug makers to drop patent challenges that could lead to the earliest possible sales of their copycat medicines.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[AstraZeneca Settles Suit, Protecting Crestor]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/03/25/astrazeneca-settles-suit-protecting-crestor/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/03/25/astrazeneca-settles-suit-protecting-crestor/</guid>
<pubDate><![CDATA[Mon, 25 Mar 2013 05:25:02 EDT]]></pubDate>
<description><![CDATA[AstraZeneca PLC (AZN) Monday said it had settled a long-running patent lawsuit with three generic drug makers, in a move which will help safeguard revenue from top-selling drug Crestor until 2016.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Top Court to Decide on Deals to Delay Cheaper Drugs]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2013/03/22/top-court-to-decide-on-deals-to-delay-cheaper-drugs/?]]></link>
<guid>http://www.foxbusiness.com/industries/2013/03/22/top-court-to-decide-on-deals-to-delay-cheaper-drugs/</guid>
<pubDate><![CDATA[Fri, 22 Mar 2013 11:19:20 EDT]]></pubDate>
<description><![CDATA[The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off the market.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/medicine_pills_health_care.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Actavis CEO on Reducing Health-Care Costs with Biosimilar Drugs]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2176253858001/actavis-ceo-on-reducing-health-care-costs-with-biosimilar-drugs/?]]></link>
<guid>http://video.foxbusiness.com/v/2176253858001/actavis-ceo-on-reducing-health-care-costs-with-biosimilar-drugs/</guid>
<pubDate><![CDATA[Tue, 19 Feb 2013 16:22:38 EST]]></pubDate>
<description><![CDATA[Actavis CEO Paul Bisaro on the latest trends in pharmaceuticals and the impact of the health-care law.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/021913/640/360/021913_closing_bisaro.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Concerns Rise Ahead of Amgen's Business Update Thursday]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/02/06/concerns-rise-ahead-amgen-business-update-thursday/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/02/06/concerns-rise-ahead-amgen-business-update-thursday/</guid>
<pubDate><![CDATA[Wed, 06 Feb 2013 15:16:07 EST]]></pubDate>
<description><![CDATA[Amgen Inc. (AMGN) is the world's largest biotechnology company, but it is beginning to face Big Pharma-type problems that include looming patent expirations for several best-selling drugs, competition from new rivals and increased regulatory scrutiny.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer Wins Rapamune Patent Suit Against Actavis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/31/pfizer-wins-rapamune-patent-suit-against-actavis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/31/pfizer-wins-rapamune-patent-suit-against-actavis/</guid>
<pubDate><![CDATA[Thu, 31 Jan 2013 18:01:32 EST]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) said it won its patent infringement suit against Actavis Inc. (ACT) in a federal court in Delaware, which now prevents Actavis from marketing its generic version of Rapamune in the U.S.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Actavis forecasts 2012 sales in excess of 2 billion euros]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/10/19/actavis-forecasts-2012-sales-in-excess-2-billion-euros/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/10/19/actavis-forecasts-2012-sales-in-excess-2-billion-euros/</guid>
<pubDate><![CDATA[Fri, 19 Oct 2012 00:03:20 EDT]]></pubDate>
<description><![CDATA[Actavis, the Swiss generic drugmaker that Watson Pharmaceuticals is taking over, said revenue would rise to more than 2 billion euros ($2.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FTC Clears Watson-Actavis Deal, With Conditions]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/10/15/ftc-clears-watson-actavis-deal-with-conditions/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/10/15/ftc-clears-watson-actavis-deal-with-conditions/</guid>
<pubDate><![CDATA[Mon, 15 Oct 2012 17:45:04 EDT]]></pubDate>
<description><![CDATA[The Federal Trade Commission on Monday cleared Watson Pharmaceuticals Inc.'s (WPI) proposed $5.9 billion acquisition of Swiss rival Actavis, but required the companies to sell the rights and assets to 18 drugs as a condition of government approval.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[U.S. High Court Rejects Allergan Patent Appeal]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2012/10/15/us-high-court-rejects-allergan-patent-appeal/?]]></link>
<guid>http://www.foxbusiness.com/industries/2012/10/15/us-high-court-rejects-allergan-patent-appeal/</guid>
<pubDate><![CDATA[Mon, 15 Oct 2012 11:01:46 EDT]]></pubDate>
<description><![CDATA[The U.S. Supreme Court on Monday rejected Allergan's challenge of a June patent ruling that favored generic drugmaker Watson Pharmaceuticals.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[FDA Withdrawing Approval of 1 Impax/Teva Generic Wellbutrin Product]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/10/03/fda-withdrawing-approval-1-impaxteva-generic-wellbutrin-product/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/10/03/fda-withdrawing-approval-1-impaxteva-generic-wellbutrin-product/</guid>
<pubDate><![CDATA[Wed, 03 Oct 2012 18:30:35 EDT]]></pubDate>
<description><![CDATA[One version of generic Wellbutrin comes off U.S. market -FDA tests show generic not as effective as brand name -FDA asking other drug makers to conduct additional tests WASHINGTON--The highest strength of a generic version of the antidepressant Wellbutrin, marketed by a unit of Teva Pharmaceuticals Ltd. (TEVA, TEVA.TV), will be taken off the U.S. market after tests showed it didn't work as well as the brand name drug.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[U.S. finds no wrongdoing in Yasmin patent settlement]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/10/02/us-finds-no-wrongdoing-in-yasmin-patent-settlement/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/10/02/us-finds-no-wrongdoing-in-yasmin-patent-settlement/</guid>
<pubDate><![CDATA[Tue, 02 Oct 2012 16:07:33 EDT]]></pubDate>
<description><![CDATA[U.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Jumbo Deals Push Monthly Corporate Bond Volume to $115 Billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/09/27/jumbo-deals-push-monthly-corporate-bond-volume-to-115-billion/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/09/27/jumbo-deals-push-monthly-corporate-bond-volume-to-115-billion/</guid>
<pubDate><![CDATA[Thu, 27 Sep 2012 16:02:53 EDT]]></pubDate>
<description><![CDATA[Two jumbo-size bond deals are bringing some life back to the corporate-debt market after a couple of quiet sessions.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Health Care Sector Wrap]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/08/24/health-care-sector-wrap/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/08/24/health-care-sector-wrap/</guid>
<pubDate><![CDATA[Fri, 24 Aug 2012 16:48:52 EDT]]></pubDate>
<description><![CDATA[The Health Care sector (XLV) showed little change during trading today while the S&P 500 rose 0.6%.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly &amp;, Limited Brands Included in Stocks Up on High Volume Friday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/08/24/eli-lilly-amp-limited-brands-included-in-stocks-up-on-high-volume-friday/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/08/24/eli-lilly-amp-limited-brands-included-in-stocks-up-on-high-volume-friday/</guid>
<pubDate><![CDATA[Fri, 24 Aug 2012 12:33:29 EDT]]></pubDate>
<description><![CDATA[A few stocks are up on high volume today: Eli Lilly & (NYSE:LLY) is seeing its price rise on above-normal volume today, as 29.7 million shares, six times the stock's average daily volume, have moved.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Kraft Foods, Sherwin-Williams, Other Stocks Hit 52-Week Highs Friday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/08/24/kraft-foods-sherwin-williams-other-stocks-hit-52-week-highs-friday/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/08/24/kraft-foods-sherwin-williams-other-stocks-hit-52-week-highs-friday/</guid>
<pubDate><![CDATA[Fri, 24 Aug 2012 12:33:21 EDT]]></pubDate>
<description><![CDATA[These are the nine most popular stocks that rose to 52-week highs: While trading on below-average volume, Kraft Foods (NASDAQ:KFT) improved today, reaching and then surpassing its previous 52-week high of $41.60.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
